Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Aid, albumin, Alpine, Amgen, arrival, assumption, Baili, balistilimab, banned, Betta, Biden, Bio, Biocad, BPCIA, Chinese, competitor, Compugen, corroborating, distancing, eastern, Emeryville, EQRx, exemplified, extubated, forgiven, Genrix, Gloria, guideline, hacking, hematological, HK, Houdeaoke, Inhibrx, invariant, judicial, killer, Kuur, liver, lymphoma, Macau, masked, Maxinovel, MSS, myeloma, NA, NaN, neuroendocrine, NKT, omitted, paclitaxel, pair, parent, Paycheck, Phyton, pneumonia, PPP, predicated, reconfiguring, Republic, Rock, runway, SBA, Scholar, Servier, Shandong, signature, streamlined, Taiwan, Taizhou, tenant, TQL, unachieved, unclear, unlimited, version, VISION, week, Xencor
Removed:
absence, adjustable, array, Basel, BTTC, Charlottesville, closure, CMV, commenced, commensurate, concurrently, CSL, deductibility, deducting, EpiVax, expensing, feasibility, GMP, heading, incurring, Jena, modification, molecular, Northwest, OncoMed, Ono, optimization, prioritization, progression, rationale, recoverable, refinancing, revalued, Suzhou, territorial, unexercised, warrant, Zermatt
Filing tables
Filing exhibits
Related press release
Associated AGEN transcripts
AGEN similar filings
Filing view
External links